Ad
related to: moderna
Search results
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 3 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 7 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 hours agoThe company also unveiled promising results in people age 18 to 59 years old with underlying...
FDA approves Moderna’s mRNA RSV vaccine for older adults
KOMU Columbia· 6 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
AOL· 1 hour agoThe FDA's advisory is in line with European and World Health Organization recommendations and comes after the U.S. agency's advisers overwhelmingly backed the targeting of the older JN.1 variant ...
COVID Shots Should Target JN.1 Variant in 2024-25 Campaign, US FDA Says
US News & World Report· 1 hour agoThe advisers recommended the older strain as it is the only strain which Novavax - one of the vaccine makers - said it would be able to target with its shot. Separately, another vaccine maker ...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 4 days agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...
An mRNA Melanoma Vaccine Shows Promise
Time via Yahoo News· 7 days agoCredit - Getty Images Moderna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company...
FDA approves Moderna’s mRNA RSV vaccine for older adults
KTBS Shreveport· 7 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s RSV arsenal in the fall. Moderna’s shot is the third ...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 4 days agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study. The ...